Loading company…
Variational AI uses generative AI to identify and create small molecules for drug discovery.
Variational AI develops the Enki™ Platform, a generative AI tool for identifying and generating drug-like small molecules across biological targets. It works with biopharmaceutical partners on therapeutic discovery. Founded in 2019, the company is based in Vancouver, Canada. In February 2025, it raised USD 5.5 mn in Seed funding led by Nimbus Synergies, with participation from Defined Capital, Merck Global Health Innovation Fund, Quimby Investments (VCC) Ltd. and ThresholdImpact.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in